HUTCHMED (China) Limited (HK:0013) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HUTCHMED (China) Limited has appointed Dr. Chaohong Hu as an Independent Non-executive Director and a member of its Technical Committee, effective November 21, 2024. Dr. Hu brings over 20 years of experience in biopharmaceuticals, including leadership roles in therapeutic antibody development and strategic partnerships. This appointment is expected to infuse fresh insights into the company’s board, enhancing its strategic direction in the biopharmaceutical industry.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.